Andrew Powell
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew Powell
Andrew Powell was last confirmed as Board Member at Lifecore Biomedical, Inc. \De\ (LFCR) in a filing dated August 31, 2020. Aclaris Therapeutics, Inc. reported in an 8-K filed March 19, 2024 that Andrew Powell resigned as member of the board of directors, effective June 6, 2024. ARS Pharmaceuticals, Inc. reported in an 8-K filed November 8, 2022 that Andrew Powell resigned as director, effective November 8, 2022.
“On March 14, 2024, Andrew Powell, a member of the board of directors (the "Board") of Aclaris Therapeutics, Inc. (the "Company"), notified the Company of his intent to resign as a member of the Board, effective as of the date of the Company's 2024 Annual Meeting of Stockholders, which is expected to be held on June 6, 2024 (the "Annual Meeting").”
“each of Vicki L. Capps, Robert Hershberg, M.D., Ph.D., Maria Koehler, M.D., Ph.D., Andrew Powell, J.D. and Jonathan Root, M.D. resigned from the Company's board of directors and any respective committee membership of the Company's board of directors, effective as of the consummation of the Merger”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2018-01-01–2020-08-31
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.